Telix Pharmaceuticals (TLX) Debt to Equity (2023 - 2024)
Telix Pharmaceuticals has reported Debt to Equity over the past 2 years, most recently at $1.0 for Q4 2024.
- Quarterly Debt to Equity rose 1530.78% to $1.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 through Dec 2024, up 1530.78% year-over-year, with the annual reading at $1.0 for FY2024, 1530.78% up from the prior year.
- Debt to Equity was $1.0 for Q4 2024 at Telix Pharmaceuticals, up from $0.06 in the prior quarter.
- Over five years, Debt to Equity peaked at $1.0 in Q4 2024 and troughed at $0.06 in Q4 2023.